Kevin Connolly - Net Worth and Insider Trading

Kevin Connolly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Connolly owns 1 companies in total, including Interpace Biosciences Inc (IDXG) .

Click here to see the complete history of Kevin Connolly’s form 4 insider trades.

Insider Ownership Summary of Kevin Connolly

Ticker Comapny Transaction Date Type of Owner
IDXG Interpace Biosciences Inc 2006-02-15 Executive vice-president

Kevin Connolly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin Connolly Ownership Network

Ownership Network List of Kevin Connolly

No Data

Ownership Network Relation of Kevin Connolly

Insider Network Chart

Kevin Connolly Owned Company Details

What does Interpace Biosciences Inc do?

Who are the key executives at Interpace Biosciences Inc?

Kevin Connolly is the Executive vice-president of Interpace Biosciences Inc. Other key executives at Interpace Biosciences Inc include Principal Financial Officer Christopher Mccarthy , director & President and CEO Thomas W. Burnell , and 10 percent owner Peter H Kamin .

Interpace Biosciences Inc (IDXG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interpace Biosciences Inc (IDXG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interpace Biosciences Inc (IDXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interpace Biosciences Inc (IDXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Interpace Biosciences Inc Insider Transactions

No Available Data

Kevin Connolly Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Connolly. You might contact Kevin Connolly via mailing address: C/o Saddle River Exec.ctr., 1 Route 17 S, Saddle River Nj 07458.

Discussions on Kevin Connolly

No discussions yet.